MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: GTCbio - Biopharmaceutical Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Rick King, VP at IAVI to Present on HIV Vaccine Design at GTC’s Vaccines Conference on July 8-10 in Boston - Rick King, Vice President of Vaccine Design at the International Aids Vaccine Initiative, will present on “New Approaches to HIV Vaccine Design” at GTC’s 11th Vaccines Research & Development: All Things Considered Conference on July 8 10, 2013 in Boston
Rick King, VP at IAVI to Present on HIV Vaccine Design at GTC’s Vaccines Conference on July 8-10 in Boston

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/05/21 - Rick King, Vice President of Vaccine Design at the International Aids Vaccine Initiative, will present on “New Approaches to HIV Vaccine Design” at GTC’s 11th Vaccines Research & Development: All Things Considered Conference on July 8 10, 2013 in Boston.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Generation of a broadly effective HIV vaccine will require a solution to the problem of HIV diversity. Recent results of the RV144 trial suggest that a vaccine is possible and that the elicitation of antibody responses may be critical for activity. Unfortunately, the generation of broadly neutralizing antibodies by vaccination has so far proved unsuccessful. New approaches are emerging that may overcome this hurdle. These include developing highly specific immunogens that mimic the antigenic determinants recognized by broadly neutralizing antibodies found in infected people. Another is to deliver mimics of the native functional Envelope spike that is the target of all broadly neutralizing antibodies identified so far. Developing vaccines to deliver native Envelope spikes has proved to be challenging and the immunogens tested to date do not assume a fully native conformation. Dr. King’s presentation will highlight how IAVI has generated replication competent virus vectors that express Envelope in a native configuration in transduced cells and on the virus particle surface. These new immunogens are currently being tested in animal systems. Benefits of this talk include:

• Introduction to the requirements of a broadly effective HIV Vaccine.
• Use of new technologies to define the targets of broadly neutralizing antibodies.
• Use of new technologies to display immunogens.
• New ways to analyze immunogenicity results.

Rick King is the Vice President of Vaccine Design, overseeing a comprehensive AIDS vaccine discovery program that includes an AIDS Vaccine Design & Development Laboratory in Brooklyn, the Neutralizing Antibody Center at the Scripps Research Institute in La Jolla, California and a New Translational Research laboratory in Delhi India. Rick has been the author and recipient of many peer reviewed grants, is an inventor on 12 issued patents, and has published more than 90 peer-reviewed publications.

The 11th Vaccines Research & Development: All Things Considered Conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions on the future of the discipline.

This conference is part of our Infectious Diseases World Summit 2013 and will be held concurrently with two other tracks which are:

2nd Influenza Research and Development
10th Anti-Infectives Partnering and Deal-Making

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Rick King, VP at IAVI to Present on HIV Vaccine Design at GTC’s Vaccines Conference on July 8-10 in Boston

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  TransPerfect

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)